Correlation Between Salesforce and Galectin Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salesforce and Galectin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Galectin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Galectin Therapeutics, you can compare the effects of market volatilities on Salesforce and Galectin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Galectin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Galectin Therapeutics.

Diversification Opportunities for Salesforce and Galectin Therapeutics

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Salesforce and Galectin is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Galectin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galectin Therapeutics and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Galectin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galectin Therapeutics has no effect on the direction of Salesforce i.e., Salesforce and Galectin Therapeutics go up and down completely randomly.

Pair Corralation between Salesforce and Galectin Therapeutics

Considering the 90-day investment horizon Salesforce is expected to generate 0.65 times more return on investment than Galectin Therapeutics. However, Salesforce is 1.53 times less risky than Galectin Therapeutics. It trades about 0.24 of its potential returns per unit of risk. Galectin Therapeutics is currently generating about 0.04 per unit of risk. If you would invest  27,371  in Salesforce on August 30, 2024 and sell it today you would earn a total of  5,630  from holding Salesforce or generate 20.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Salesforce  vs.  Galectin Therapeutics

 Performance 
       Timeline  
Salesforce 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.
Galectin Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Galectin Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting essential indicators, Galectin Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Salesforce and Galectin Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salesforce and Galectin Therapeutics

The main advantage of trading using opposite Salesforce and Galectin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Galectin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galectin Therapeutics will offset losses from the drop in Galectin Therapeutics' long position.
The idea behind Salesforce and Galectin Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance